001     12405
005     20200402205927.0
024 7 _ |2 pmid
|a pmid:20922735
024 7 _ |2 DOI
|a 10.1002/anie.201004437
024 7 _ |2 WOS
|a WOS:000284045400042
024 7 _ |2 ISSN
|a 0570-0833
024 7 _ |a altmetric:21805123
|2 altmetric
037 _ _ |a PreJuSER-12405
041 _ _ |a eng
082 _ _ |a 540
084 _ _ |2 WoS
|a Chemistry, Multidisciplinary
100 1 _ |0 P:(DE-HGF)0
|a Müller-Schiffmann, A.
|b 0
245 _ _ |a Combining independent drug classes into superior, synergistically acting hybrid molecules
260 _ _ |a Weinheim
|b Wiley-VCH
|c 2010
295 1 0 |a Angewandte Chemie International Edition English
300 _ _ |a 8743 - 8746
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |0 6077
|a Angewandte Chemie
|v 49
|x 0044-8249
|y 46
500 _ _ |a The major support for this work was from a grant of the Volkswagen-Stiftung to C. K., T. S., D. W., and H. S. (I/82 649); further funding was provided by EU-FP6 (cNEUPRO), EU-FP7 (PRIORITY) grants to C. K. and a DFG-GRK1033 grant to J.K. and C. K.
536 _ _ |0 G:(DE-Juel1)FUEK409
|2 G:(DE-HGF)
|a Funktion und Dysfunktion des Nervensystems
|c P33
|x 0
536 _ _ |0 G:(DE-Juel1)FUEK505
|2 G:(DE-HGF)
|a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|c P45
|x 1
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Amino Acid Sequence
650 _ 2 |2 MeSH
|a Amyloid beta-Peptides: chemistry
650 _ 2 |2 MeSH
|a Animals
650 _ 2 |2 MeSH
|a CHO Cells
650 _ 2 |2 MeSH
|a Cricetinae
650 _ 2 |2 MeSH
|a Cricetulus
650 _ 2 |2 MeSH
|a Drug Design
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Immunoprecipitation
650 _ 2 |2 MeSH
|a Oligopeptides: chemistry
650 _ 2 |2 MeSH
|a Oligopeptides: pharmacology
650 _ 2 |2 MeSH
|a Protein Structure, Secondary
650 _ 2 |2 MeSH
|a Pyrazoles: chemistry
650 _ 2 |2 MeSH
|a Stereoisomerism
650 _ 7 |0 0
|2 NLM Chemicals
|a Amyloid beta-Peptides
650 _ 7 |0 0
|2 NLM Chemicals
|a D3 peptide
650 _ 7 |0 0
|2 NLM Chemicals
|a Oligopeptides
650 _ 7 |0 0
|2 NLM Chemicals
|a Pyrazoles
650 _ 7 |0 0
|2 NLM Chemicals
|a trimer-TEG-D3
650 _ 7 |2 WoSType
|a J
653 2 0 |2 Author
|a aggregation
653 2 0 |2 Author
|a amyloid beta peptides
653 2 0 |2 Author
|a drug design
653 2 0 |2 Author
|a molecular recognition
653 2 0 |2 Author
|a peptides
700 1 _ |0 P:(DE-Juel1)VDB95646
|a März-Berberich, J.
|b 1
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Andrjevna, A.
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Rönicke, R.
|b 3
700 1 _ |0 P:(DE-Juel1)VDB65461
|a Bartnik, D.
|b 4
|u FZJ
700 1 _ |0 P:(DE-Juel1)VDB89561
|a Brener, O.
|b 5
|u FZJ
700 1 _ |0 P:(DE-Juel1)VDB95649
|a Kutzsche, J.
|b 6
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Horn, A.H.C.
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Hellmert, M.
|b 8
700 1 _ |0 P:(DE-HGF)0
|a Gottmann, K
|b 9
700 1 _ |0 P:(DE-HGF)0
|a Reymann, K.
|b 10
700 1 _ |0 P:(DE-Juel1)VDB65869
|a Funke, S. A.
|b 11
|u FZJ
700 1 _ |0 P:(DE-Juel1)VDB72731
|a Nagel-Steger, L.
|b 12
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Moriscot, C.
|b 13
700 1 _ |0 P:(DE-HGF)0
|a Schoehn, G.
|b 14
700 1 _ |0 P:(DE-HGF)0
|a Sticht, H.
|b 15
700 1 _ |0 P:(DE-Juel1)132029
|a Willbold, D.
|b 16
|u FZJ
700 1 _ |0 P:(DE-Juel1)VDB77919
|a Schrader, T.
|b 17
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Korth, C.
|b 18
773 _ _ |0 PERI:(DE-600)2011836-3
|a 10.1002/anie.201004437
|g Vol. 49, p. 8743 - 8746
|p 8743 - 8746
|q 49<8743 - 8746
|t Angewandte Chemie / International edition
|v 49
|x 0044-8249
|y 2010
856 7 _ |u http://dx.doi.org/10.1002/anie.201004437
909 C O |o oai:juser.fz-juelich.de:12405
|p VDB
913 1 _ |0 G:(DE-Juel1)FUEK409
|a DE-HGF
|b Gesundheit
|k P33
|l Funktion und Dysfunktion des Nervensystems
|v Funktion und Dysfunktion des Nervensystems
|x 0
913 1 _ |0 G:(DE-Juel1)FUEK505
|a DE-HGF
|b Schlüsseltechnologien
|k P45
|l Biologische Informationsverarbeitung
|v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|x 1
914 1 _ |a Angew Chem Int Ed Engl 2010 Nov.8; 49(46): 8743-6
|y 2010
915 _ _ |0 StatID:(DE-HGF)0010
|2 StatID
|a JCR/ISI refereed
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer review
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
920 1 _ |0 I:(DE-Juel1)VDB942
|d 31.12.2010
|g ISB
|k ISB-3
|l Strukturbiochemie
|x 0
970 _ _ |a VDB:(DE-Juel1)124021
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21